Skip to content

Clinical trials

Phase 2 Pleural Effusion, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 2 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20062
20074
20082
20092
20102
20112
20121
20131
20142
20152
20163
20181
20201
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status9
Terminated5
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
University of Washington2
Abramson Cancer Center at Penn Medicine1
Asan Medical Center1
Canadian Cancer Trials Group1
Cancer Trials Ireland1
Eli Lilly and Company1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant34
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms5
Neoplasm Metastasis5
Adenocarcinoma of Lung4
Carcinoma, Ovarian Epithelial3
Fallopian Tube Neoplasms3
Pleural Effusion3
Ovarian Neoplasms2
Pericardial Effusion2

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.